Related by context. All words. (Click for frequent words.) 67 Destination Therapy 63 generation rotary VAD 62 Levacor 60 EchoCRT 60 Pivotal Trial 59 CHAMPION PCI 59 rALLy clinical trial 59 Augment Injectable 59 ENDEAVOR IV 59 Novacor LVAS 59 Phase 2b kidney transplant 58 RELIANT Trial 58 ABSORB trial 58 phase IIb clinical 58 SUCCEED trial 58 MIST II 57 Phase Ib II 57 TAXUS IV 57 drug eluting stent DES 56 lorcaserin Phase 56 APEX PD 56 Vertos 56 phase IIa clinical 56 EASE Trial 56 SEPET TM 56 AFRS TM 56 LVAS 56 ABSORB clinical 55 Combo Stent 55 PROTECT AF 55 phase IIIb 55 HeartMate R 55 multicenter prospective 55 Levacor VAD 55 CardioWest TAH t 55 DuraHeart 55 BrachySil TM 55 Randomized Evaluation 55 ExCell study 55 prospective multicenter 55 DEEP AF 54 ALSYMPCA 54 Levacor TM 54 Phase IIIb clinical 54 HeartMate II 54 CoAxia 54 IMPACT DCM trial 54 BST CarGel R 54 Phase IIIb study 54 placebo controlled Phase III 54 eluting stent 54 StemEx 54 Phase Ib clinical 54 DAPT Study 54 Novacor R 54 REVIVE Diabetes 54 Biliary System 54 GEM OS1 54 REALITY Trial 54 MEND CABG 54 multicenter clinical 54 Phase #b/#a clinical 54 randomized controlled Phase 54 TAXUS TM 54 Phase lll 54 phase IIb trial 54 VTE prevention 54 CRMD# 54 PFO migraine 54 PRECISE Trial 54 Eluting Stent 54 Orqis Medical 54 seliciclib CYC# 54 ACCEDE 54 Phase 2b study 54 Phase Ib study 53 Phase IIb kidney transplant 53 sunitinib malate 53 Phase #b/#a 53 ASCEND HF 53 KYTHERA 53 multicenter randomized controlled 53 CLIRS trial 53 XIENCE V Everolimus Eluting 53 Feasibility Trial 53 Phase III randomized controlled 53 Edwards SAPIEN valve 53 Endurant 53 multicenter Phase 53 Vascular Wrap TM 53 TBC# 53 PrevOnco ™ 53 ALN VSP Phase 53 Dural Sealant 53 prospective multicenter randomized 53 ROCKET AF 53 Embolic Protection Device 53 ENGAGE AF TIMI 53 StemEx R 53 CentriMag 53 PARTNER Trial 53 confirmatory Phase III 53 GEM OS2 53 herpetic keratitis 53 Zemplar Capsules 53 MEND CABG II 53 initiated Phase Ib 53 DuraHeart LVAS 53 BLA filing 53 CALGB 53 dose escalation phase 53 VESTASYNC II trial 53 zileuton IV 53 ZYBRESTAT fosbretabulin 53 PRESEPT 52 VentrAssist 52 OvaRex R 52 CardioFit 52 everolimus eluting stent 52 Bayer HealthCare Onyx Pharmaceuticals 52 Neovasc Reducer 52 EVEREST II 52 Phase Ib 52 PANVAC VF 52 SUPERA stent 52 Acute Decompensated Heart Failure 52 Phase #b/#a trial 52 XIENCE TM 52 phase III SIMPADICO 52 Ascendra 52 RESTORE CLI trial 52 Genous 52 Amrubicin 52 PROVENGE ® 52 fully bioabsorbable 52 COSIRA trial 52 novel oral anticoagulant 52 PROLARIS 52 Medtronic CoreValve ® 52 randomized Phase 2b 52 Phase III metastatic melanoma 52 CONQUER OB 52 phase III ACCLAIM 52 PrevOnco 52 multicenter randomized Phase 52 Phase #/#a 52 Urocortin 2 52 ReValving System 52 multicenter randomized clinical 52 Circulatory Support 52 Phase III pivotal 52 XVE 52 TAXUS Liberte 52 carotid endarterectomy CEA 52 HeartMate ® 52 Refractory Angina 52 Urocidin 52 multicenter clinical trials 52 OZURDEX ® 52 TAXUS V 52 OLYMPIA registry 51 IMPACT DCM clinical 51 PROTEGE 51 Vascugel 51 Phase III HEAT 51 Gentamicin Surgical Implant 51 Phase III randomized 51 oral ridaforolimus 51 Factor VIIa 51 transfemoral 51 HDL Selective Delipidation 51 Phase IIb trials 51 REVEAL Registry 51 RX ACCULINK 51 Delcath Phase III 51 BioSTAR R 51 steroid refractory 51 Acute Ischemic Stroke 51 granted Ortec 51 ORBIT II 51 NOX E# 51 placebo controlled randomized 51 hypoxia activated prodrug 51 Iluvien TM 51 dose escalation Phase 51 Endeavor drug eluting 51 pain palliation 51 PROMUS Element Stent 51 Stabilimax 51 BioSTAR ® 51 Simulect 51 octreotide implant 51 Fx #A 51 randomized Phase IIb 51 MYTHOS trial 51 HeartMate XVE 51 BRIM2 51 catheter occlusion 51 Medtronic CoreValve 51 unique alkylating agent 51 multicenter phase 51 Phase IIb clinical trials 51 initiate multicenter 51 Emboshield 51 Phase IIa trial 51 Phase 1b 51 everolimus eluting stents 51 double blinded randomized 51 HORIZONS AMI trial 51 Ketotransdel 51 HeartMate 51 registrational trial 51 Vascular Wrap 51 wide receiver Kenbrell Thompkins 51 BioMatrix TM 51 randomized discontinuation 51 MKC# MKC# PP 51 Sirolimus eluting Coronary Stent 51 transcatheter aortic 51 bardoxolone 51 ICON7 51 Phase IIb trial 51 Endoscopic Ablation System 51 ExCell 51 confirmatory pivotal 51 Panzem R NCD 51 Phase III TRIST 51 Phase IIb III 51 Terumo Heart 51 prospective randomized multicenter 50 acyclovir Lauriad R 50 DuraHeart TM 50 placebo controlled clinical 50 Facet Solutions 50 Troxatyl 50 placebo controlled multicenter 50 Prospective Randomized 50 BLP# Liposome Vaccine 50 Vascugel ® 50 STENT 50 multicentre randomized 50 transapical 50 PDE4 inhibitor 50 NSABP C 50 initiate Phase IIb 50 LibiGel BioSante 50 enroller 50 Lung Rx 50 CYPHER SELECT TM 50 Phase IIIb 50 HeartNet 50 pivotal bioequivalence 50 IN.PACT 50 AIM HIGH 50 Phase III 50 Recurrent Glioblastoma 50 PREOS R 50 sapacitabine CYC# 50 deforolimus 50 NeoDisc 50 GLP toxicology studies 50 EOquin TM 50 AIMM trial 50 ReN# 50 XIENCE V stent 50 RenalGuard System TM 50 Dose Ranging Study 50 Octreolin 50 Novacor 50 BioSTAR TM 50 TAXUS ATLAS 50 TNFerade ™ 50 multicenter Phase II 50 BR.# 50 VESTASYNC 50 Resolute DES 50 VITAL Trial 50 SUTENT ® 50 Archexin 50 regorafenib 50 SIR Spheres 50 TAXUS Liberté stent 50 BrachySil ™ 50 biventricular 50 MADIT II 50 phase IIb study 50 Kamada AAT 50 oxypurinol 50 Phase III Psoriasis 50 myoblast therapy 50 AIR2 Trial 50 ONCONASE R 50 TRO# 50 assessing T DM1 50 drug eluting coronary stent 50 BioMatrix 50 ADVANCE PD 50 TAXUS Element Paclitaxel Eluting 50 exploratory Phase IIa 50 Zilver PTX stent 50 rALLy 50 clinical trial 50 Xcellerated T Cells 50 multicenter randomized placebo controlled 50 Fibrillex TM 50 APTIVUS 50 confirmatory Phase 50 glucokinase activator 49 RE MODEL 49 PROTECT II 49 OMP #R# 49 prospective randomized 49 oral picoplatin 49 NO# [002] 49 trodusquemine 49 Glufosfamide 49 MacuSight 49 Catheter Ablation 49 ZYBRESTAT TM 49 YONDELIS 49 Intravitreal 49 NovaVision VRT 49 phase IIa 49 Litx 49 multicentre randomized double 49 sumatriptan DosePro 49 prospective nonrandomized 49 Ceflatonin R 49 Drug Eluting Coronary Stent 49 Cloretazine 49 Neuradiab 49 lorvotuzumab mertansine 49 multicentre randomized controlled 49 Acute Coronary Syndromes ACS 49 Cardiac Dimensions 49 Phase IIa trials 49 BHT DNA 49 Phase III confirmatory 49 Phase 1b clinical 49 Axxion TM 49 Diamyd R 49 EQUIP OB 49 initiate Phase Ib 49 PDX pralatrexate 49 BFPET 49 patients undergoing CABG 49 uremic pruritus 49 inhaled treprostinil 49 Q#IR 49 GetGoal Phase III 49 dirucotide MBP# 49 Febuxostat 49 oncolytic vaccine 49 PFO closure 49 Trovax 49 Metricath Gemini 49 Bio engineered Sirolimus 49 Allovectin 7 49 factor VIIa 49 Fontan procedure 49 paclitaxel poliglumex 49 Estracure 49 MYDICAR ® 49 registrational 49 tesmilifene 49 mSEPT9 biomarker 49 Edwards SAPIEN 49 double blinded placebo 49 HuMax TAC 49 Phase III psoriasis 49 dosing cohort 49 CINTREDEKIN BESUDOTOX 49 DAPT 49 REGEN trial 49 controlled multicenter 49 Bayer Onyx 49 serine protease inhibitor CU# 49 comparing alemtuzumab 49 fosbretabulin 49 Aortic Valve 49 BRILINTA 49 Genzyme Synvisc 49 MYDICAR 49 IMC A# 49 Investigational Device Exemption IDE 48 Proxinium TM 48 Phase III LibiGel 48 Terumo Heart Inc. 48 controlled multicenter Phase 48 Medidur TM FA 48 HeFT 48 phase Ib 48 Stabilimax NZ 48 RESOLUTE clinical 48 Attrius ® 48 COSTAR II 48 Initiates Phase 2b 48 Spine Patient Outcomes 48 Aplidin 48 cathepsin K inhibitor 48 dermaPACE 48 initiate Phase 1b 48 ZACTIMA 48 MyoCell 48 Zilver PTX 48 MoxDuo IR 48 OncoGel 48 Ventricular Assist Device VAD 48 azilsartan medoxomil 48 ACCLAIM II 48 ProLindac TM 48 OVATURE trial 48 MoxDuo 48 EDEMA3 48 ONTARGET 48 RE LY ® 48 saphenous vein graft 48 Protalex 48 apricitabine ATC 48 omacetaxine mepesuccinate 48 randomized Phase III 48 CALGB # [002] 48 PSMA ADC 48 FVIIa 48 Xanafide 48 Xelox 48 TURBO Booster 48 RIGScan CR 48 evaluating picoplatin 48 Sirolimus eluting 48 iFuse Implant System 48 EVICEL 48 NCCTG 48 Self Expanding Stent 48 Canvaxin TM 48 BioSante LibiGel Phase III 48 IMPACT IMmunotherapy 48 clevidipine 48 randomizing patients 48 APEX AMI 48 BLOOM Behavioral modification 48 Augment Injectable Bone Graft 48 Medidur ™ FA 48 Amoxicillin PULSYS Phase III 48 TAXUS Stent 48 immunomodulatory therapy 48 Bexion 48 ICD therapy 48 3 registrational trial 48 Relovair 48 AdhTAP 48 Stereotactic Body Radiation Therapy 48 Phase Ia 48 VBLOC TM 48 GLASS ART Trial 48 KIACTA ™ 48 alvespimycin 48 Ophthotech 48 RELIANT 48 OPT CHF 48 CO2 TMR 48 sargramostim 48 Aneurysm Repair 48 MVax 48 multicenter randomized double 48 randomized multicenter 48 Pertuzumab 48 Trevo System 48 evaluating Actimmune 48 CryoValve SG 48 Aflibercept 48 including eniluracil ADH 48 IV Busulfex 48 QTinno 48 Heart Transplant Recipients 48 Multicenter 48 AQ4N 48 HALO# [002] 47 ZYBRESTAT 47 BioNumerik 47 intravesical infusion therapy 47 dose escalation clinical 47 Mipomersen 47 MARVEL Trial 47 Pivotal Phase II 47 Oral NKTR 47 Pulminiq 47 STARFlex ® 47 anterior lumbar interbody fusion 47 AZX# Phase 47 fenretinide 47 IN.PACT Falcon 47 FlowCardia 47 AGGRASTAT ® 47 deCODE AF TM 47 E1 INT TM 47 unresectable Stage III 47 cartilage regeneration 47 Abbokinase 47 Acetavance TM intravenous acetaminophen 47 iCardiac 47 RHEO 47 Harry Palmin President 47 DUROS 47 Cloretazine R VNP#M 47 opioid bowel dysfunction 47 product TNFerade TM 47 NSABP 47 acute PAO 47 initiate Phase IIa 47 Cysteamine 47 generation PNP inhibitor 47 Phase 1a clinical 47 Allovectin 7 ® 47 cetrorelix pamoate 47 Advanced Heart Failure 47 BAY #-# 47 kidney urologic 47 XL# anticancer compounds 47 compound INCB# 47 ticagrelor Brilinta 47 Percutaneous Transluminal Coronary Angioplasty 47 preclinical studies Vion 47 EMPOWER ™ 47 Cardio3KG 47 Phase 1a 47 Albuferon Phase 47 BLOOM DM 47 Cardiva 47 ARISE Phase III 47 Luveniq 47 Liprostin 47 BCIRG 47 Angioblast 47 QNEXA ® 47 HepeX B TM 47 XmAb 47 unblinding 47 LCP Tacro 47 PediaFlow VAD 47 Cinacalcet HCl 47 postoperative ileus POI 47 Phase 2a trial 47 leading oral taxane 47 Visian Toric ICL 47 RhuDex ® 47 System LVAS 47 VTEUs 47 Genous Bio engineered 47 Marvin Slepian 47 Oncotype DX colon cancer 47 Ozurdex 47 Impella 47 Vernakalant 47 BST CarGel 47 Telintra 47 Angiotensin Therapeutic Vaccine 47 AVAX 47 molecular chaperone regulation 47 ADP receptor antagonist 47 WX UK1 47 Thrombin 47 Ophena 47 RIGScan 47 Nipent R 47 PROPEL 47 RESOLUTE 47 Nanobody R 47 MADIT 47 vidofludimus 47 Stenting Trial 47 initiate Phase 2b 47 Angiocept 47 Phase Ib IIa clinical 47 Thorough QT 47 PRIMO CABG 47 Xerecept 47 multicentre prospective 47 Initiate Phase 47 successfully commercialize Iluvien 47 SYN# 47 Heart Transplantation 47 PRESEPT study 47 Urodynamix 47 ASCT 47 Medidur FA 47 Tacrolimus 47 TOLAMBA 47 Cypher Stent 47 Pre RELAX AHF 47 metastatic CRPC 47 vascular disrupting agent 47 receptor tyrosine kinase inhibitor 47 Novacor II 47 small molecule chemotherapeutic 47 STOP AF 47 Exherin TM 47 VANTAS ® 47 VIAject ® 47 TMC# C# 47 Lixivaptan 46 ELACYT 46 CCX# B 46 Loramyc R 46 octreotide 46 topically applied SEPA 46 sNDA submission 46 bifurcated stent 46 Teflaro 46 Onconova 46 Demineralized Bone Matrix 46 includes TOLAMBA TM 46 ThermoDox R 46 orally administered inhibitor 46 Angiox R 46 Enable valve 46 ENRICH trial 46 Fabry Disease 46 Alzhemed TM 46 ILUVIEN 46 acute ischemic stroke 46 subconjunctival injection 46 Carotid 46 ClearPath HDR 46 AIR CF1 46 cryosurgical treatment 46 EOquin 46 developing ViaCyte SM 46 HCD# [002] 46 Charles Dullin School 46 multicenter 46 abiraterone acetate 46 Multicenter Automatic Defibrillator Implantation 46 sequential dose escalation 46 Teysuno 46 LibiGel ® Phase III 46 somatostatin analog 46 Parathyroid Hormone 46 Chemophase 46 Shigamabs 46 CBLC# 46 direct thrombin inhibitors 46 ELONVA 46 Phase IIA 46 Transplant BTT 46 palifosfamide 46 Quinamed 46 sapacitabine 46 Symadex 46 II Clinical Trial 46 Solesta 46 macitentan 46 GERD migraine headaches 46 Mepact 46 Randomised 46 ongoing Phase IIIb 46 FluoroPharma 46 OMS# 46 FORTIS M trial 46 ProFibrix 46 budesonide MMX Phase III 46 Acute MI 46 thorough QTc 46 GW# [003] 46 DF HCC 46 RE COVER 46 Sonatherm 46 Long Lesion 46 LC Bead 46 evaluating intravenous picoplatin 46 Rescula 46 diagnosed glioblastoma 46 Dacogen decitabine 46 inhaled AAT 46 Trofex 46 MoxDuo TM IR 46 volociximab 46 Zavesca r 46 topically administered 46 LibiGel ® testosterone gel 46 ORE# 46 Aphthasol R 46 onset AF 46 blinded randomized placebo controlled 46 denosumab oncology clinical trials 46 randomized clinical 46 Arcion 46 Zerenex 46 metastatic RCC 46 Diametrics 46 Arginox 46 Sibutramine Cardiovascular Outcomes 46 XYOTAX TM 46 Adhesion Barrier 46 Stereotaxis System 46 Pedicle Screw System 46 5 FU CVC 46 Genz # 46 AMPAKINE compound 46 HuMax CD#b 46 pharmacokinetic PK study 46 Cellegy Pharmaceuticals Inc. 46 GORE TAG Device 46 Arthroplasty 46 Arno Therapeutics 46 OREXIGEN 46 Anturol TM 46 Invisalign Assist 46 Gliadel Wafer 46 intravenous dosing 46 Taxus Liberté 46 brentuximab vedotin SGN 46 GRN# 46 multicentre 46 Toraymyxin TM 46 Dalbavancin 46 DEB# 46 Initiated Phase 46 TransMID 46 next generation URAT1 46 docetaxel Taxotere ® 46 blind multicenter 46 Durata 46 candidate blinatumomab MT# 46 ICAEL 46 Tavocept 46 Resten NG 46 trastuzumab Herceptin R 46 refractory colorectal cancer 46 liposomal doxorubicin 46 randomized #:#:# 46 romidepsin novel 45 blinded randomized 45 Zirgan 45 CorPath 45 Irinotecan 45 DIIG 45 Calmare pain 45 OrbusNeich Genous Bio 45 torezolid phosphate 45 Transplantation BTT 45 Ablatherm 45 Spheramine 45 UA NSTEMI 45 Blinatumomab 45 PressureWire 45 investigational humanized monoclonal antibody 45 Left Atrial Appendage 45 Proneuron 45 Mimpara 45 observational cohort 45 TriReme 45 INKP 45 ritonavir boosted danoprevir 45 EXCOR R 45 selective androgen receptor modulator 45 budesonide MMX ® 45 Integrium 45 Cethromycin 45 EXCITE 45 TandemHeart System 45 chemoprevention trials 45 Bradmer 45 EGS# 45 Ceragenin ™ 45 TroVax ® 45 Alvesco R 45 antibody MAb 45 Hsp# Inhibitor 45 preclinical efficacy 45 liver transplant recipients 45 Vancocin ® 45 Traficet EN 45 SpideRX 45 Dabigatran etexilate 45 SoftScan ® 45 Vasomedical enhanced 45 RLY# 45 Endarterectomy 45 coflex 45 APF# Phase 45 KRN# 45 muscarinic receptor agonists 45 CVCTA Education 45 vosaroxin 45 epigenetic therapies 45 CardioPET 45 Oncoscience AG 45 Avastin adjuvant 45 HuMax EGFr 45 Myelodysplastic Syndrome MDS 45 Current Controlled Trials 45 ARG# 45 MEPACT 45 SCENESSE R 45 EHT AGN 45 XIENCE 45 STAR Ankle 45 HuCAL antibodies 45 Fund Distribution Reinvestment 45 plerixafor 45 Myoblast Program 45 cortical stimulation 45 ELIQUIS 45 ACTIVE W 45 beta 1a 45 transoral 45 juvenile chondrocytes 45 viral kinetic 45 QNEXA 45 MicroMed Cardiovascular Inc. 45 Severe Sepsis 45 Resynchronization 45 warfarin therapy 45 orally dosed 45 myoblast 45 drug eluting balloons 45 DMD DMSc 45 Thorough QT Study 45 apricitabine 45 Phase 2a preventative 45 Dendreon Provenge 45 fallopian tube cancers 45 neratinib 45 recombinant PSMA vaccine 45 tanespimycin 45 HIV maturation inhibition 45 PatientKeeper Charge Capture 45 SIMPADICO 45 tolerability pharmacokinetics 45 BIO SET 45 Accuray CyberKnife 45 PEGylated interferon 45 American HealthChoice 45 #:# randomization 45 Diabetic Retinopathy DR 45 Plexur M TM 45 GlucoLight 45 Mycophenolate Mofetil 45 Medifacts 45 CMV vaccine 45 Autologous 45 INT# [002] 45 denosumab oncology 45 AGGRASTAT R tirofiban hydrochloride 45 neuropathy sparing 45 EnteroMedics proprietary neuroblocking technology 45 saphenous vein grafts 44 Brinavess 44 Caris Dx 44 MyoSure 44 Aeroquin 44 MACUGEN 44 Neupogen ® 44 LUMINATE pivotal clinical 44 PI3K/Akt pathway inhibitor 44 MET amplification 44 randomized #:# 44 ENDEAVOR 44 Anterior Cervical 44 Fracture Intervention Trial 44 Single Incision 44 Xinlay 44 Unite Biomatrix 44 blinded placebo controlled 44 Teladoc 44 Tryton 44 APPRAISE 44 NP2 Enkephalin 44 Pitavastatin 44 Doxil ® 44 prelicensure 44 Carotid endarterectomy 44 liposomal formulation 44 ASSERT 44 Cethrin 44 metastatic renal cell carcinoma 44 midstage clinical trials 44 UPLYSO 44 intranasal insulin product 44 candidate deforolimus 44 Xcelerant Delivery System 44 medically inoperable 44 Interventional Spine 44 chemoradiation therapy 44 exploratory endpoints 44 treatment naive genotype 44 CA4P 44 eplerenone 44 MGCD# clinical trials 44 Lixte 44 bovine tissue 44 HMPL 44 CYTC 44 Curacyte AG 44 OMAPRO 44 NCIC CTG 44 EndoTAG TM -1 44 CCX# 44 Bellicum 44 AmpliMed 44 laparoscopic radical nephrectomy 44 Digital Mammographic Imaging 44 Phase III ADT 44 bevacizumab Avastin ® 44 romidepsin 44 OMP #M# 44 Fentanyl Taifun 44 Lilly Gemzar 44 MedPulser 44 capecitabine Xeloda 44 Occluder 44 systemic sclerosis SSc 44 rFactor XIII 44 Provecta 44 RTOG 44 Fenretinide 44 VBLOC ™ 44 XP# XP# 44 ART# 44 freestanding diagnostic imaging 44 EMPOWER TM 44 RH1 targeted chemotherapeutic agent 44 Onrigin TM 44 LEVADEX ™ 44 RE LY trial 44 peripheral arterial 44 benign prostatic hyperplasia enlarged 44 LANTUS ® 44 Resten MP 44 Inclinix 44 HeartWare HVAD 44 NeuroAid TM 44 candidate brentuximab vedotin 44 LCP AtorFen 44 Angiotech Pharma 44 MGN# 44 OnDose TM 44 Ultrasonix 44 Imedex 44 immunotherapeutic vaccine 44 DSMB 44 Syndax Pharmaceuticals Inc. 44 incyclinide 44 ATIR ™ 44 resorptive 44 Trinam 44 stated Michelle Berrey 44 Unifill 44 Anavex #-# 44 recurrent metastatic ovarian cancer 44 hereditary deficiency 44 Kogenate R 44 Kb Port 44 Zyclara 44 recurrent malignant glioma 44 monoclonal antibody biologic 44 humanised monoclonal antibody 44 CORD II 44 WHRT 44 Soliris therapy 44 pharmacodynamic effects 44 IAP inhibitor 44 PD2i Analyzer 44 bioabsorbable stent 44 AMD# [003] 43 MAXY VII 43 Trofex TM 43 ACAPODENE TM 43 XIENCE V PROMUS Stent 43 multicenter dose escalation 43 Mersana 43 ProMune 43 Increlex R 43 PTH analogue 43 Carticept 43 Cimzia TM 43 platelet inhibitor 43 DSMB recommended 43 uroNIRS 43 Mozobil 43 Granulocyte Colony Stimulating Factor 43 PharPoint 43 neural crest stem cell 43 Cardiosonix 43 JZP 6 43 TheraCIM 43 Azedra TM 43 Cand5 43 Nexavar ® 43 pegylated liposomal doxorubicin PLD 43 Christian Itin Ph.D. 43 BioControl 43 DIABECELL 43 Healionics 43 Rcadia 43 Vaxfectin TM 43 unblinded 43 CRRT